EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RARs and microRNAs



RARs and microRNAs



Sub-Cellular Biochemistry 70: 151-179



MicroRNA MicroRNA s (miRNAs) are small noncoding RNAs acting as endogenous regulators of gene expression. Their discovery is one of the major recent breakthroughs in molecular biology. miRNAs establish a multiplicity of relationships with target mRNAs and exert pleiotropic biological effects in many cell physiological pathways during development and adult life. The dynamic nature of gene expression regulation by Retinoic Acid Retinoic acid (RA) is consistent with an extensive functional interplay with miRNA activities. In fact, RA regulates the expression of many different miRNAs, thus suggesting a relevant function of miRNAs in RA-controlled gene expression programmes. miRNAs have been extensively studied as targets and mediators of the biological activity of RA during embryonic development as well as in normal and neoplastic cells. However, relatively few studies have experimentally explored the direct contribution of miRNA function to the RA signalling pathway. Here, we provide an overview of the mechanistic aspects that allow miRNA biogenesis, functional activation and regulation, focusing on recent evidence that highlights a functional interplay between miRNAs and RA-regulated molecular networks. We report examples of tissue-specific roles of miRNAs modulated by RA in stem cell pluripotency maintenance and regeneration, embryonic development, hematopoietic and neural differentiation, and other biological model systems, underlining their role in disease pathogenesis. We also address novel areas of research linking the RA signalling pathway to the nuclear activity of miRNAs.

(PDF emailed within 0-6 h: $19.90)

Accession: 055333357

Download citation: RISBibTeXText

PMID: 24962885

DOI: 10.1007/978-94-017-9050-5_8



Related references

Is RARS-T a new disease entity or a subtype of RARS or ET?. Korean Journal of Hematology 45(2): 139-140, 2010

Development of Smart Optical Gels with Highly Magnetically Responsive Bicelles. Acs Applied Materials & Interfaces, 2018

Lymphocyte subsets in RA and RARS. Leukemia Research 23(SUPPL 1): S30, April, 1999

RARS with fibrosis and del(20q) transformed into ALL. Medical Oncology 29(5): 3570-3573, 2013

Mutations in RARS cause hypomyelination. Annals of Neurology 76(1): 134-139, 2014

The role of JAK2 mutations in RARS and other MDS. Hematology. American Society of Hematology. Education Program: 52-59, 2009

Retinoid status and RARs expression. Journal of Nutritional Science and Vitaminology Spec No: 477-480, 1992

RARS with fibrosis and del2q transformed into ALL. 2012

Global and local competition between exogenously introduced microRNAs and endogenously expressed microRNAs. Molecules and Cells 37(5): 412-417, 2015

Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chinese Medical Journal 122(20): 2405-2411, 2010

Functional profiling of precursor MicroRNAs identifies MicroRNAs essential for glioma proliferation. Plos One 8(4): E60930-E60930, 2013

MicroRNAs targeting the immunomodulatory HLA-G gene: a new survey searching for microRNAs with potential to regulate HLA-G. Molecular Immunology 65(2): 230-241, 2015

Pharmacogenetics of microRNAs and microRNAs biogenesis machinery in pediatric acute lymphoblastic leukemia. Plos One 9(3): E91261-E91261, 2016

Micromanaging microRNAs: using murine models to study microRNAs in lung fibrosis. Drug Discovery Today. Disease Models 10(3): E145-E151, 2014

Efficient silencing of endogenous microRNAs using artificial microRNAs in Arabidopsis thaliana. Molecular Plant 4(1): 157-170, 2011